FDA Inspection
Interstate Blood Bank Inc of MissouriInterstate Blood Bank Inc of Missouri – FDA Inspection, Jan 26, 2011
Record Details
This FDA Inspection record concerns Interstate Blood Bank Inc of Missouri, with an inspection on January 26, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 26, 2011
- Product Type
- Biologics
View Company Profile
ID · df8de885-1007-495e-a59d-4241a4d9cee0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 708520
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Interstate Blood Bank Inc of Missouri
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 1, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 6, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 10, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 29, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 27, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Interstate Blood Bank Inc of Missouri
- FDA Inspection 1146155 - 2021-06-01
- FDA Inspection 1077021 - 2018-12-06
- FDA Inspection 943915 - 2015-09-10
- FDA Inspection 817191 - 2013-01-29
- FDA Inspection 571852 - 2009-03-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.